Propanc Biopharma executes 1-for-10 reverse stock split on Nasdaq
Tweet Send to a Friend
Propanc Biopharma, Inc. (NASDAQ: PPCB), a biopharmaceutical company based in Melbourne, Australia, announced that its board of directors approved a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




